Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lannett Company, Inc. stock logo
LCI
Lannett
$1.54
$0.64
$3.72
$7.38M0.9592,067 shs280,600 shs
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
$4.10
+2.4%
$3.69
$1.61
$9.50
$340.64M0.911.10 million shs1.33 million shs
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
$0.13
-0.3%
$0.13
$0.10
$0.21
$43.79M1.0727,482 shs17,350 shs
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
$1.67
$1.87
$0.63
$2.60
$194.21M-0.36578,697 shs287,232 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lannett Company, Inc. stock logo
LCI
Lannett
0.00%0.00%0.00%0.00%0.00%
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
+1.01%+3.36%-0.25%+45.99%-40.21%
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
-3.81%-3.60%-8.24%+12.54%-27.61%
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
-1.76%-9.73%-15.23%+4.37%+96.47%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lannett Company, Inc. stock logo
LCI
Lannett
$1.54
$0.64
$3.72
$7.38M0.9592,067 shs280,600 shs
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
$4.10
+2.4%
$3.69
$1.61
$9.50
$340.64M0.911.10 million shs1.33 million shs
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
$0.13
-0.3%
$0.13
$0.10
$0.21
$43.79M1.0727,482 shs17,350 shs
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
$1.67
$1.87
$0.63
$2.60
$194.21M-0.36578,697 shs287,232 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lannett Company, Inc. stock logo
LCI
Lannett
0.00%0.00%0.00%0.00%0.00%
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
+1.01%+3.36%-0.25%+45.99%-40.21%
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
-3.81%-3.60%-8.24%+12.54%-27.61%
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
-1.76%-9.73%-15.23%+4.37%+96.47%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Lannett Company, Inc. stock logo
LCI
Lannett
0.00
N/AN/AN/A
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
3.00
Buy$18.43349.92% Upside
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
0.00
N/AN/AN/A
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest TLSA, LCI, LRMR, and SEOVF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/15/2025
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
JMP Securities
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetMarket Outperform$22.00 ➝ $18.00
6/24/2025
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
6/24/2025
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
Wedbush
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$17.00 ➝ $15.00
6/24/2025
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$26.00
(Data available from 9/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Lannett Company, Inc. stock logo
LCI
Lannett
$340.58M0.00N/AN/A($23.34) per share0.00
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
N/AN/AN/AN/A$2.69 per shareN/A
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/AN/AN/AN/A($0.03) per shareN/A
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
N/AN/AN/AN/A$0.04 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Lannett Company, Inc. stock logo
LCI
Lannett
-$231.62M-$18.88N/AN/AN/A-62.40%N/A-13.39%N/A
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
-$80.60M-$1.56N/AN/AN/AN/A-62.92%-53.98%10/29/2025 (Estimated)
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
-$23.65M-$0.04N/AN/AN/AN/A-378.98%N/A
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
-$11.86MN/A0.00N/AN/AN/AN/A10/13/2025 (Estimated)

Latest TLSA, LCI, LRMR, and SEOVF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/15/2025Q3 2025
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
-$0.0144-$0.01+$0.0044-$0.01N/AN/A
8/14/2025Q2 2025
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
-$0.47-$0.41+$0.06-$0.41N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Lannett Company, Inc. stock logo
LCI
Lannett
N/AN/AN/AN/AN/A
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
N/AN/AN/AN/AN/A
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/AN/AN/AN/AN/A
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Lannett Company, Inc. stock logo
LCI
Lannett
N/A
2.23
1.39
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
N/A
5.46
5.46
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/A
0.12
0.12
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
N/A
1.02
1.02

Institutional Ownership

CompanyInstitutional Ownership
Lannett Company, Inc. stock logo
LCI
Lannett
40.28%
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
91.92%
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/A
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
N/A

Insider Ownership

CompanyInsider Ownership
Lannett Company, Inc. stock logo
LCI
Lannett
13.12%
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
4.50%
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/A
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
39.82%
CompanyEmployeesShares OutstandingFree FloatOptionable
Lannett Company, Inc. stock logo
LCI
Lannett
81010.77 million9.35 millionOptionable
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
3082.78 million79.05 millionOptionable
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/A328.48 millionN/ANot Optionable
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
8116.85 million70.32 millionOptionable

Recent News About These Companies

Tiziana Life Sciences doses first patient in Phase 2a MSA trial
Tiziana Life Sciences Ltd (TLSA) - Yahoo Finance

New MarketBeat Followers Over Time

Media Sentiment Over Time

Lannett stock logo

Lannett NYSE:LCI

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.

Larimar Therapeutics stock logo

Larimar Therapeutics NASDAQ:LRMR

$4.10 +0.10 (+2.40%)
As of 03:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. Larimar Therapeutics, Inc. is based in Bala Cynwyd, Pennsylvania.

Sernova Biotherapeutics stock logo

Sernova Biotherapeutics OTCMKTS:SEOVF

$0.13 0.00 (-0.30%)
As of 11:46 AM Eastern

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.

Tiziana Life Sciences stock logo

Tiziana Life Sciences NASDAQ:TLSA

$1.67 0.00 (0.00%)
As of 03:54 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti- receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.Kingdom.